• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利什曼病中的免疫反应:概述

Immune Responses in Leishmaniasis: An Overview.

作者信息

Costa-da-Silva Ana Caroline, Nascimento Danielle de Oliveira, Ferreira Jesuino R M, Guimarães-Pinto Kamila, Freire-de-Lima Leonardo, Morrot Alexandre, Decote-Ricardo Debora, Filardy Alessandra Almeida, Freire-de-Lima Celio Geraldo

机构信息

Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21944-970, Brazil.

Instituto de Veterinária, Universidade Federal Rural do Rio de Janeiro, Seropédica 23890-000, Brazil.

出版信息

Trop Med Infect Dis. 2022 Mar 31;7(4):54. doi: 10.3390/tropicalmed7040054.

DOI:10.3390/tropicalmed7040054
PMID:35448829
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9029249/
Abstract

Leishmaniasis is a parasitic, widespread, and neglected disease that affects more than 90 countries in the world. More than 20 species cause different forms of leishmaniasis that range in severity from cutaneous lesions to systemic infection. The diversity of leishmaniasis forms is due to the species of parasite, vector, environmental and social factors, genetic background, nutritional status, as well as immunocompetence of the host. Here, we discuss the role of the immune system, its molecules, and responses in the establishment, development, and outcome of Leishmaniasis, focusing on innate immune cells and interactions.

摘要

利什曼病是一种寄生虫病,广泛传播且被忽视,全球有90多个国家受到影响。20多种利什曼原虫会引发不同形式的利什曼病,其严重程度从皮肤损伤到全身感染不等。利什曼病形式的多样性归因于寄生虫种类、传播媒介、环境和社会因素、遗传背景、营养状况以及宿主的免疫能力。在此,我们讨论免疫系统及其分子和反应在利什曼病的发生、发展和转归中的作用,重点关注固有免疫细胞及其相互作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f18/9029249/fdd2626d3106/tropicalmed-07-00054-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f18/9029249/fdd2626d3106/tropicalmed-07-00054-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f18/9029249/fdd2626d3106/tropicalmed-07-00054-g001.jpg

相似文献

1
Immune Responses in Leishmaniasis: An Overview.利什曼病中的免疫反应:概述
Trop Med Infect Dis. 2022 Mar 31;7(4):54. doi: 10.3390/tropicalmed7040054.
2
Deception and manipulation: the arms of leishmania, a successful parasite.欺骗与操控:利什曼原虫(一种成功的寄生虫)的手段
Front Immunol. 2014 Oct 20;5:480. doi: 10.3389/fimmu.2014.00480. eCollection 2014.
3
Understanding the immune responses involved in mediating protection or immunopathology during leishmaniasis.了解在利什曼病中介导保护或免疫病理学的免疫反应。
Biochem Soc Trans. 2021 Feb 26;49(1):297-311. doi: 10.1042/BST20200606.
4
Protective or Detrimental? Understanding the Role of Host Immunity in Leishmaniasis.保护还是有害?了解宿主免疫在利什曼病中的作用。
Microorganisms. 2019 Dec 13;7(12):695. doi: 10.3390/microorganisms7120695.
5
Exploring the paradox of defense between host and Leishmania parasite.探讨宿主与利什曼原虫寄生虫之间防御的悖论。
Int Immunopharmacol. 2022 Jan;102:108400. doi: 10.1016/j.intimp.2021.108400. Epub 2021 Dec 8.
6
Interleukin-10 and Transforming Growth Factor-β in Early and Late Lesions of Patients with Leishmania major Induced Cutaneous Leishmaniasis.杜氏利什曼原虫引起的皮肤利什曼病患者早期和晚期病变中的白细胞介素-10和转化生长因子-β
Iran J Parasitol. 2012;7(3):16-23.
7
Interleukin-10 and Transforming Growth Factor-β in Early and Late Lesions of Patients with Leishmania major induced Cutaneous Leishmaniasis.利什曼原虫主要引起的皮肤利什曼病患者早期和晚期病变中的白细胞介素-10和转化生长因子-β
Iran J Parasitol. 2012;7(2):53-60.
8
PKDL and other dermal lesions in HIV co-infected patients with Leishmaniasis: review of clinical presentation in relation to immune responses.合并感染HIV的利什曼病患者的皮肤利什曼病后皮肤黏膜病变及其他皮肤病变:与免疫反应相关的临床表现综述
PLoS Negl Trop Dis. 2014 Nov 20;8(11):e3258. doi: 10.1371/journal.pntd.0003258. eCollection 2014.
9
The Impact of Neutrophil Recruitment to the Skin on the Pathology Induced by Infection.中性粒细胞向皮肤募集对感染诱导的病理学的影响。
Front Immunol. 2021 Mar 1;12:649348. doi: 10.3389/fimmu.2021.649348. eCollection 2021.
10
In Search of Biomarkers for Pathogenesis and Control of Leishmaniasis by Global Analyses of -Infected Macrophages.通过对感染巨噬细胞的全球分析寻找利什曼病发病机制和控制的生物标志物。
Front Cell Infect Microbiol. 2018 Sep 19;8:326. doi: 10.3389/fcimb.2018.00326. eCollection 2018.

引用本文的文献

1
Repositioning of moxidectin: a promising approach in cutaneous leishmaniasis therapy.莫昔克丁的重新定位:皮肤利什曼病治疗中的一种有前景的方法。
Parasite. 2025;32:42. doi: 10.1051/parasite/2025035. Epub 2025 Jul 4.
2
Commentary on the Issue of Infection: Focus on Some Pathogenetic, Clinical, and Epidemiological Aspects.感染问题述评:聚焦一些发病机制、临床及流行病学方面
Vet Sci. 2025 Jun 1;12(6):536. doi: 10.3390/vetsci12060536.
3
Squamous Cell Carcinoma in Chronic Cutaneous Leishmaniasis: Coincidence or Malignant Transformation.

本文引用的文献

1
Phlebotomine sand flies (Diptera: Psychodidae) of the Maghreb region: A systematic review of distribution, morphology, and role in the transmission of the pathogens.北非地区的嗜人按蚊(双翅目:长角亚目):分布、形态学和在病原体传播中的作用的系统综述。
PLoS Negl Trop Dis. 2022 Jan 6;16(1):e0009952. doi: 10.1371/journal.pntd.0009952. eCollection 2022 Jan.
2
Hide-and-Seek: A Game Played between Parasitic Protists and Their Hosts.捉迷藏:寄生原生生物与其宿主之间的一场游戏
Microorganisms. 2021 Nov 25;9(12):2434. doi: 10.3390/microorganisms9122434.
3
Blockade of TLR2 and TLR4 Attenuates Inflammatory Response and Parasite Load in Cutaneous Leishmaniasis.
慢性皮肤利什曼病中的鳞状细胞癌:巧合还是恶性转化?
Cureus. 2025 May 24;17(5):e84720. doi: 10.7759/cureus.84720. eCollection 2025 May.
4
Unravelling drug resistance in leishmaniasis: genomic adaptations and emerging therapies.揭示利什曼病的耐药性:基因组适应性与新兴疗法
Front Mol Biosci. 2025 May 26;12:1573618. doi: 10.3389/fmolb.2025.1573618. eCollection 2025.
5
RNA synthesis in is constitutive during stage conversion: a genome-wide PRO-seq analysis.在阶段转换过程中,RNA合成是组成型的:全基因组PRO-seq分析。
Microbiol Spectr. 2025 Jul;13(7):e0056625. doi: 10.1128/spectrum.00566-25. Epub 2025 Jun 9.
6
Miltefosine analogues with comparable antileishmanial activity and significantly reduced macrophage cytotoxicity.具有相当抗利什曼原虫活性且巨噬细胞细胞毒性显著降低的米替福新类似物。
Mem Inst Oswaldo Cruz. 2025 May 26;120:e240219. doi: 10.1590/0074-02760240219. eCollection 2025.
7
Visceral Leishmaniasis in Pediatrics: A Case Series and a Narrative Review with Global Insights.儿童内脏利什曼病:病例系列及全球视角的叙述性综述
Trop Med Infect Dis. 2025 May 17;10(5):136. doi: 10.3390/tropicalmed10050136.
8
Hepatic alveolar echinococcosis infection induces a decrease in NK cell function through high expression of NKG2A in patients.肝泡型包虫病感染通过患者体内NKG2A的高表达导致自然杀伤细胞功能下降。
Front Immunol. 2025 May 12;16:1563248. doi: 10.3389/fimmu.2025.1563248. eCollection 2025.
9
IL-32-producing CD8+ memory T cells define immunoregulatory niches in human cutaneous leishmaniasis.产生白细胞介素-32的CD8+记忆性T细胞在人类皮肤利什曼病中定义了免疫调节生态位。
J Clin Invest. 2025 May 15;135(10). doi: 10.1172/JCI182040.
10
Itaconate: A Nexus Metabolite Fueling Survival Through Lipid Metabolism Modulation.衣康酸:一种通过调节脂质代谢促进生存的关键代谢物
Microorganisms. 2025 Feb 27;13(3):531. doi: 10.3390/microorganisms13030531.
阻断 TLR2 和 TLR4 可减轻皮肤利什曼病的炎症反应和寄生虫载量。
Front Immunol. 2021 Oct 6;12:706510. doi: 10.3389/fimmu.2021.706510. eCollection 2021.
4
Evasion of the complement system by Leishmania through the uptake of factor H, a complement regulatory protein.利什曼原虫通过摄取补体调节蛋白因子 H 来逃避补体系统。
Acta Trop. 2021 Dec;224:106152. doi: 10.1016/j.actatropica.2021.106152. Epub 2021 Sep 30.
5
Leishmaniasis: the act of transmission.利什曼病:传播行为。
Trends Parasitol. 2021 Nov;37(11):976-987. doi: 10.1016/j.pt.2021.07.003. Epub 2021 Aug 10.
6
Leishmaniasis.利什曼病
Indian J Crit Care Med. 2021 May;25(Suppl 2):S166-S170. doi: 10.5005/jp-journals-10071-23844.
7
Emerging and Re-emerging Infectious Diseases in the WHO Eastern Mediterranean Region, 2001-2018.《2001-2018 年世卫组织东地中海区域新发和再发传染病》
Int J Health Policy Manag. 2022 Aug 1;11(8):1286-1300. doi: 10.34172/ijhpm.2021.13. Epub 2021 Mar 6.
8
Constitutive nitric oxide synthase-like enzyme in two species involved in cutaneous and mucocutaneous leishmaniasis.两种参与皮肤和黏膜利什曼病的物种中的组成型一氧化氮合酶样酶。
Parasitol Int. 2021 Aug;83:102347. doi: 10.1016/j.parint.2021.102347. Epub 2021 Apr 19.
9
The global procurement landscape of leishmaniasis medicines.利什曼病药物的全球采购格局。
PLoS Negl Trop Dis. 2021 Feb 18;15(2):e0009181. doi: 10.1371/journal.pntd.0009181. eCollection 2021 Feb.
10
Understanding the immune responses involved in mediating protection or immunopathology during leishmaniasis.了解在利什曼病中介导保护或免疫病理学的免疫反应。
Biochem Soc Trans. 2021 Feb 26;49(1):297-311. doi: 10.1042/BST20200606.